A Birth Year Cohort and What It Can Reveal About Lipid Mediators as Putative Biomarkers of Progression in Multiple Sclerosis

Affiliations

¹ From the Department of Medicine (D.R., R.S.), Division of Neurology, University of Toronto; St. Michael's Hospital (D.R., R.S.), and Keenan Research Centre for Biomedical Science (R.S.), Unity Health Toronto, Ontario, Canada. dalia.rotstein@unityhealth.to.
² From the Department of Medicine (D.R., R.S.), Division of Neurology, University of Toronto; St. Michael's Hospital (D.R., R.S.), and Keenan Research Centre for Biomedical Science (R.S.), Unity Health Toronto, Ontario, Canada.

Editorial

Dalia Rotstein et al. Neurology. 2023.

. 2023 Aug 1;101(5):197-198.

doi: 10.1212/WNL.0000000000207605. Epub 2023 Jun 8.

¹ From the Department of Medicine (D.R., R.S.), Division of Neurology, University of Toronto; St. Michael's Hospital (D.R., R.S.), and Keenan Research Centre for Biomedical Science (R.S.), Unity Health Toronto, Ontario, Canada. dalia.rotstein@unityhealth.to.
² From the Department of Medicine (D.R., R.S.), Division of Neurology, University of Toronto; St. Michael's Hospital (D.R., R.S.), and Keenan Research Centre for Biomedical Science (R.S.), Unity Health Toronto, Ontario, Canada.

No abstract available

Comment on

Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis.
Broos JY, Loonstra FC, de Ruiter LRJ, Gouda M, Fung WH, Schoonheim MM, Heijink M, Strijbis EMM, Teunissen C, Killestein J, de Vries HE, Giera M, Uitdehaag BMJ, Kooij G. Broos JY, et al. Neurology. 2023 Aug 1;101(5):e533-e545. doi: 10.1212/WNL.0000000000207459. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290971 Free PMC article.